Aligos Therapeutics (ALGS) Preferred Shares (2019 - 2020)
Aligos Therapeutics (ALGS) reported Preferred Shares of $14.6 million for Q3 2020, up 358.73% quarter-over-quarter from $3.2 million in Q4 2019.
Aligos Therapeutics (ALGS) Preferred Shares (2019 - 2020) Analysis & Trends
Aligos Therapeutics has reported Preferred Shares for 2 years, with the latest figure at $14.6 million in Q3 2020.
- For the quarter ending Q3 2020, Preferred Shares changed N/A year-over-year to $14.6 million; the trailing twelve-month figure through Sep 2020 stood at $14.6 million (changed N/A YoY), and the FY2019 full-year result was $3.2 million, changed N/A from the prior year.
- Preferred Shares for Q3 2020 stood at $14.6 million, up from $3.2 million in the prior quarter.
- The five-year high for Preferred Shares was $14.6 million in Q3 2020, with the low at $3.2 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Aligos Therapeutics | 54.72 Mn | -25.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 14.56 Mn |
| Dec 31, 2019 | 3.17 Mn |